Skip to content

Clinical trials

Obesity trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Country / region: Bulgaria Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20131
20171
20183
20223
20233
20259
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Completed8
Active, not recruiting8
Not yet recruiting3
Terminated3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S15
Amgen3
Kailera3
Pfizer3
Boehringer Ingelheim2
Eli Lilly and Company2
Anne Birgitte Raben1
AstraZeneca1
BTL Industries Ltd.1
Fundació d'investigació Sanitària de les Illes Balears1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity35
Overweight19
Diabetes Mellitus, Type 28
Diabetes Mellitus5
Heart Failure3
Hypertension2
Nutrition Disorders2
Osteoarthritis, Knee2
Atherosclerosis1
Body Weight1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.